AYUSH-64 : A Miraculous Remedy in Covid-19

Shivani Sharma; Pankaj  Sharma

Shivani Sharma Post Graduate Scholar, Department of Rasa Shastra and Bhaishajya Kalpana, Post Graduate Training and Research Institute, Government Ayurvedic College, Patiala, Punjab, India.
Pankaj Sharma Lecturer, Department of Kayachikitsa, Post Graduate Training and Research Institute, Government Ayurvedic College, Patiala, Punjab, India.

Keywords: Covid-19, SARS-CoV2, Ayush-64, Immuno-modulatory, Antioxidant, Phytoconstituents

Abstract

Tracing back to Dec. 2019 when the first case of Novel Corona Virus disease was reported, the global community is still living in fear of Covid-19 disease due to repeatedly emerging new variants of SARS-CoV2. Even the vaccines developed till date cannot fully prevent the spread of this highly contagious disease posing significant global health burden. In such devastating times Ayurveda system of medicine is a beacon of hope for thousands of people. Ayush-64 is an Ayurvedic formulation which was developed by the Central Council for Research in Ayurvedic Sciences (CCRAS), Ministry of AYUSH and Govt. of India for the management of Malaria. It has four ingredients having immunomodulatory, febrifugal, anti-oxidant and antiviral activities. The experimental studies done on Ayush-64 showed that its phytoconstituents have high binding affinity against Covid-19 virus. Therefore, it has also been encompassed in the National Covid management protocol based on Ayurveda and Yoga by GOI for asymptomatic, mild, moderate cases of Covid-19. The potential of Ayurveda has been already seen worldwide during pandemic times. This is our humble attempt to explore the effect of Ayush-64 in Covid-19.

Downloads

Download data is not yet available.

References

Rumain B, Schneiderman M, Geliebter A. Prevalence of COVID-19 in adolescents and youth compared with older adults in states experiencing surges. PLoS One. 2021 Mar 10;16 (3):e0242587. doi: 10.1371/journal.pone.0242587. PMID: 33690600; PMCID: PMC7946189. [Accessed 31.07.22].

Sarkar A, Chakrabarti AK, Dutta S. Covid-19 Infection in India: A Comparative Analysis of the Second Wave with the First Wave. Pathogens. 2021 Sep 21;10(9):1222. doi: 10.3390/pathogens10091222. PMID: 34578254; PMCID: PMC8469101. [Accessed 31.07.22].

https://www.bbc.com/news/world-asia-india-56891016 [Accessed 31.07.22].

P.V. Sharma, Charak Samhita. Varanasi: Chaukhamba Orientalia; 2008

Murthy KS. Susruta Samhita. Varanasi: Chaukhamba Orientalia; 2008

https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html [Accessed 07.08.22].

P.V. Sharma (Ed.), Charaka Samhita of Agnivesha, Vol. II, Choukhambha Orientalia, Varanasi (2011)

A.K. Nadkarni, Indian Materia Medica, Vol. I, Bombay, Popular Prakashan.

Dr. C.K. Kokate, A.P.Purohit, S.B. Gokhale, Pharmacognosy, Vol. I & II, 46th Ed., Nirali Prakashan

P.V. Sharma, Dravyagun Vigyan, Part II, Choukhambha Bharti Academy, Varanasi.

M.V. Chari, S. Venkataraghavan, C. Seshadri, B.R. Shetty, N. Gowri. A double-blind clinical trial with Ayush-64 an Ayurvedic drug in P. vivax Malaria. J Res Ay Sid, 6 (3–4) (1982), pp. 105-116

D. Bhatia. Role of AYUSH-64 in malaria epidemic. J Res Ay Sid, 18 (1- 2) (1997), pp. 71-76

K.D. Sharma, M.L. Kapoor, S.P. Vaidya, L.K. Sharma. A clinical trial of “Ayush-64” (A coded antimalarial medicine) in cases of malaria. J Res Ay Sid, II (4) (2017)

Anonymous. Ayush-64 A new ayurvedic anti- malarial compound. Central Council for Research in Ayurveda and Siddha, Ministry of Health & Family Welfare, Govt. of India (1987)

P.N. Pandey, P. Kishore. Effect of Ayush-64 and Saptaparnaghana Vati on microfilaraemia. J Res Ay Sid, 12 (3–4) (1989), pp. 145-150

Anonymous. Management of chikungunya through Ayurveda and Siddha- A technical report. Central Council for Research in Ayurvedic Sciences, Department of Ayush, Ministry of Health & Family Welfare, Government of India (2009)

M.S. Gundeti, L.W. Bhurke, P.S. Mundada, S. Murudkar, A. Surve, R. Sharma, et al. AYUSH 64, a polyherbal Ayurvedic formulation in influenza like illness: results of a pilot study. J Ayurveda Integr Med (2020), 10.1016/j.jaim.2020.05.010

A. Chopra, P. Chavan-Gautam, G. Tillu, M. Saluja, S. Borse, S. Sarmukaddam, et al. Co administration of AYUSH 64 as an adjunct to Standard of Care in mild and moderate COVID-19: a randomised, controlled, multicentric clinical trial. Preprint available at: https://www.medrxiv.org/content/10.1101/2021.06.12.21258345v1

R.G. Reddy, R.V. Gosavi, B. Yadav, A.K. Rai, M.P. Holay, M. Talekar, et al. AYUSH- 64 as an add-on to standard care in asymptomatic and mild cases of COVID- 19: a randomized controlled trial. Preprint available at: https://osf.io/pgraf/

H. Singh, S. Srivastava, B. Yadav, A.K. Rai, S. Jameela, S. Muralidharan, et al. AYUSH- 64 as an adjunct to Standard Care in mild to moderate COVID-19: an open-label randomized controlled trial in Chandigarh, India. Preprint available at:https://osf.io/xyuas/

P. Bhardwaj, P.K. Godatwar, J. Charan, S. Sharma, S. Shafi, N. Chauhan, et al. Efficacy and safety of ayurveda intervention (AYUSH 64) as add-on therapy for patients with COVID-19 infections – an open labelled, parallel group, randomized controlled clinical trial. Preprint available at:https://www.medrxiv.org/content/10.1101/2021.08.10.21261836v1 (2021)

Ministry of Ayush. Government of India. Ayurveda preventive measures for self- care during COVID-19 pandemic. Available from:https://covid19.india.gov.in/document/ayurveda-preventive-measures-for-self-care-during-covid-19-pandemic/ (2021)

Muhammad Y, Kani YA, Iliya S, Muhammad JB, Binji A, El-Fulaty Ahmad A, Kabir MB, Umar Bindawa K, Ahmed A. Deficiency of antioxidants and increased oxidative stress in COVID-19 patients: A cross-sectional comparative study in Jigawa, Northwestern Nigeria. SAGE Open Med. 2021 Feb 1;9:2050312121991246. doi: 10.1177/2050312121991246. PMID: 33614035; PMCID: PMC7871282.

Jana K, Chatterjee K, Ali KM, Ghosh A, Bera TK, Ghosh D. Antioxidant potential of hydro-methanolic extract of seed of Caesalpinia bonduc: An in vitro study. J Adv Pharm Technol Res. 2011 Oct;2(4):260-5. doi: 10.4103/2231-4040.90884. PMID: 22247894; PMCID: PMC3255348.

Kant K, Walia M, Agnihotri VK, Pathania V, Singh B. Evaluation of Antioxidant Activity of Picrorhiza kurroa (Leaves) Extracts. Indian J Pharm Sci. 2013 May;75(3):324-9. doi: 10.4103/0250-474X.117438. PMID: 24082348; PMCID: PMC3783750.

James, Joel & Thaliyil Veetil, Arun & Veettil, Thaliyil & Pratyush, Kumar & Misra, Chandra & Dev, Lipin & Sahadevan, Mundur & Thankamani, Vaidyanathan. (2011). In Vitro Antioxidant Activity of Flowers and Fruits of Alstonia scholaris. Avicenna Journal of Phytomedicine. 3. 475-479.

Chen, Yue & Huang, Bo & He, Jingsheng & Han, Li & Zhan, Yichao & Wang, Youwei. (2011). In vitro and in vivo antioxidant effects of the ethanolic extract of Swertia chirayita. Journal of ethnopharmacology. 136. 309-15. 10.1016/j.jep.2011.04.058.

Tan LY, Komarasamy TV, Rmt Balasubramaniam V. Hyperinflammatory Immune Response and COVID-19: A Double-Edged Sword. Front Immunol. 2021 Sep 30;12:742941. doi: 10.3389/fimmu.2021.742941. PMID: 34659238; PMCID: PMC8515020.

G, Sandhia & A R, Bindu. (2015). Phytochemical, anti-inflammatory and in vitro anticancer activity of Caesalpinia bonduc stem bark. International Journal of Pharma Sciences and Research 0975-9492. 6. 50-56.

Hu, Tianyong & Ju, Jian-Ming & Lihua, Mo & Ma, Li & Hu, Wen-Hui & You, Rong-Rong & Chen, Xue-Qing & Chen, Yan-Yan & Liu, Zhi-Qiang & Qiu, Shu-Qi & Fan, Jun-Ting & Cheng, Bao-Hui. (2018). Anti-inflammation Action of Xanthones from Swertia chirayita by Regulating COX-2/NF-κB/MAPKs/Akt Signaling Pathways in RAW 264.7 Macrophage cells. Phytomedicine. 55. 10.1016/j.phymed.2018.08.001.

Ngamprasertchai T, Kajeekul R, Sivakorn C, Ruenroegnboon N, Luvira V, Siripoon T, Luangasanatip N. Efficacy and Safety of Immunomodulators in Patients with COVID-19: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. Infect Dis Ther. 2022 Feb;11(1):231-248. doi: 10.1007/s40121-021-00545-0. Epub 2021 Nov 10. PMID: 34757578; PMCID: PMC8579415.

Shukla S, Mehta A, Mehta P, Vyas SP, Shivaprasad HN. In vivo immunomodulatory activities of the aqueous extract of bonduc nut Caesalpinia bonducella seeds. Pharm Biol. 2010 Feb;48(2):227-30. doi: 10.3109/13880200903085474. PMID: 20645846.

T.S. Ram, M. Munikumar, V.N. Raju, P. Devaraj, N.K. Boiroju, R. Hemalatha, et al. In silico evaluation of the compounds of the ayurvedic drug, AYUSH-64, for the action against the SARS-CoV-2 main protease. J Ayurveda Integr Med (2021), 10.1016/j.jaim.2021.02.004

Mahija K C, Nazeer K A A. Repurposing Ayush-64 for COVID-19: A Computational Study Based on Network Pharmacology and Molecular Docking. Comb Chem High Throughput Screen. 2022 Feb 10. doi: 10.2174/1386207325666220210125923. Epub ahead of print. PMID: 35142268.

https://www.mohfw.gov.in/pdf/ImmunityBoostingAYUSHAdvisory.pdf